Vidac Pharma   Report issue

For profit Phase 2
Founded: Jerusalem Israel (2011)

Organization Overview

First Clinical Trial
2016
NCT02844777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Vidac Pharma